Simvastatin Treatment Protects Myocardium in Noncoronary Artery Cardiac Surgery by Inhibiting Apoptosis Through miR-15a-5p Targeting
In the October 2018 issue of Journal of Cardiovascular Pharmacology in the article by Zhou, L., Liu, X., Wang, Z., Li, Y., Shi, M., & Xu, Z. et al, “Simvastatin Treatment Protects Myocardium in Noncoronary Artery Cardiac Surgery by Inhibiting Apoptosis Through miR-15a-5p Targeting,” the university affiliation of the author has been miss printed. Instead of, “The First Affiliated Hospital of Sun Yat-sen University” it should read as follows, “The First Affiliated Hospital, Sun Yat-sen University.”
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Zhou L, Liu X, Wang Z, et al. Simvastatin treatment Protects Myocardium in noncoronary Artery cardiac Surgery by inhibiting Apoptosis through miR-15a-5p targeting. J Cardiovasc Pharmacol. 2018;72:176–185.